Abstract
An article from the "Canada Communicable Disease Report" (CCDR) Volume 36 • Volume 36 • ACS-1, January 2010. This statement provides recommendations for use of Zostavax™ in Canadian adults. Source: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/10vol36/acs-1/index-eng.php
Americas
Canada
health policy
Herpes zoster
